No adverse events were observed in clozapine‐treated patients on extended hematologic monitoring intervals during the coronavirus pandemic in four psychiatric centers in Japan.

Autor: Hata, Masahiro1 (AUTHOR) mhata@psy.med.osaka-u.ac.jp, Fujimoto, Michiko1 (AUTHOR), Kanai, Koji1 (AUTHOR), Yoshiyama, Kenji1 (AUTHOR), Nakatani, Yoshitaka1,2 (AUTHOR), Nakabayashi, Daiji2 (AUTHOR), Maemura, Saki2 (AUTHOR), Kawata, Shinya2 (AUTHOR), Hakozaki, Takaaki2 (AUTHOR), Nishikura, Shuya2 (AUTHOR), Umemoto, Aiko2 (AUTHOR), Sasada, Toru2 (AUTHOR), Iwata, Kazuhiko2 (AUTHOR), Tanaka, Hideki3 (AUTHOR), Mamoto, Akiko3 (AUTHOR), Toi, Yuuki3 (AUTHOR), Taniguchi, Norio3 (AUTHOR), Saito, Makiko4 (AUTHOR), Kimura, Yoshio4 (AUTHOR), Kishimoto, Kazuko4 (AUTHOR)
Zdroj: Neuropsychopharmacology Reports. Jun2021, Vol. 41 Issue 2, p179-184. 6p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje